Form 4: Clarus Corp Director Roger Werner Reports Stock Option Grant
SEC Form 4
Director Roger Werner reports the acquisition of stock options in Clarus Corp.
Summary
- Roger Werner, a director of Clarus Corp, filed a Form 4 on June 3, 2024, reporting a transaction.
- On May 30, 2024, Werner was granted 20,000 stock options with an exercise price of $6.81.
- These options vest in four equal tranches of 5,000 options each on June 30, 2024, September 30, 2024, December 31, 2024, and March 31, 2025.
- Following the transaction, Werner directly owns 20,000 derivative securities (stock options).
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard stock option grant. It's positive in that it incentivizes the director, but it's a routine event.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedule incentivizes continued service and contribution to the company's success.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with shareholder value.
Stakeholder Impact
- The stock option grant could potentially increase shareholder value if the director's performance improves the company's financial results.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of stock option grant |
| 06/03/2024 | Form 4 filing date |
| 06/30/2024 | First vesting date for 5,000 options |
| 09/30/2024 | Second vesting date for 5,000 options |
| 12/31/2024 | Third vesting date for 5,000 options |
| 03/31/2025 | Fourth vesting date for 5,000 options |
| 05/30/2034 | Expiration date of the options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.